Ventricular Assist Device Trials Need Redesign, FDA And Advisers Agree
This article was originally published in The Gray Sheet
Executive Summary
FDA agrees with its advisory panel that it should work with industry to develop better trial designs for left ventricular assist devices
You may also be interested in...
NIH Group Proposes Ventricular Assist Study For “Less Sick” Patients
The National Heart Lung and Blood Institute and an interdisciplinary team of experts is trying to develop a multi-device clinical trial to test the benefits of ventricular assist devices in patients with advanced, but not end-stage, heart failure
NIH Group Proposes Ventricular Assist Study For “Less Sick” Patients
The National Heart Lung and Blood Institute and an interdisciplinary team of experts is trying to develop a multi-device clinical trial to test the benefits of ventricular assist devices in patients with advanced, but not end-stage, heart failure
Advisory Panel Votes 12-0 In Favor Of Thoratec’s HeartMate II LVAD
FDA's Circulatory System Devices panel unanimously endorsed Thoratec's PMA for its HeartMate II implantable left ventricular assist device at its Nov. 30 meeting in Gaithersburg, Md